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Abstract
Diabetes mellitus is a chronic disorder that results in hyperglycemia by absolute or relative insulin deficiency, sometimes 
leading to fatal complications. The successful treatment of diabetic dogs depends on nutritional management and 
insulin applications. Studies evaluating the nutrition of diabetic dogs focused on fiber as the main factor in glycemic 
control; however, new research describes the role of starch as key in postprandial glycemic fluctuation, also attributing 
a central role for body condition scores and feed management in the adequate glycemic control of diabetic dogs. The 
aim of this paper is to review nutritional aspects to better control diabetes in dogs.
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Resumo
Diabetes Mellitus é uma desordem crônica que resulta em hiperglicemia pela deficiência absoluta ou relativa de insulina, 
que gera complicações que podem levar à morte. O sucesso do tratamento do cão diabético depende da aplicação de 
insulina e do adequado manejo nutricional. Estudos que avaliaram aspectos nutricionais de cães diabéticos focavam na 
fibra dietética como o principal fator controlador da glicemia, porém novas pesquisas apontam o amido como principal 
responsável pelas respostas glicêmicas pós-prandiais e atribuem importante papel ao escore de condição corporal e ao 
manejo alimentar no adequado controle glicêmico de cães diabéticos. O objetivo deste trabalho é revisar os principais 
aspectos da nutrição de cães diabéticos para o melhor controle da doença.
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Introduction
Diabetes mellitus (DM) is a chronic disease that results 
in hyperglycemia due to insulin deficiency, which can lead 
to complications such as cataracts, diabetic ketoacidosis, 
coma, and death (NELSON, 1989; ZICKER et al., 2010; 
FASCETTI; DELANEY, 2012). The main treatment goal 
in dogs is to maintain glycaemia as close as possible to 
normal levels and to avoid fluctuations throughout the day 
(NELSON; LEWIS, 1990). In addition, it is important to 
control hyperlipidemia (SOTTIAUX, 1999; XENOULIS; 
STEINER, 2015). Successful treatment depends on an 
adequate nutritional management program and on insulin 
applications (GRAHAM et al., 1994).
This review compiles scientific evidence regarding 
nutritional factors that may influence glycemic and lipid 
control in DM dogs.
Starch
Most studies assessing the role of nutrition in the 
glycemic control of diabetic dogs focused on the benefits 
of increased dietary fiber intake (BLAXTER et al., 1990; 
NELSON et al., 1991, 1998; ENGLYST et al., 1992; NELSON, 
1992; GRAHAM et al., 1994; KIMMEL et al., 2000; 
GRAHAM et al., 2002). However, new research suggests 
that starch plays a key role in fluctuations of postprandial 
glucose responses in diabetic dogs (CARCIOFI et al., 2008; 
TESHIMA, 2010; TEIXEIRA, 2016).
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It is known that different types of starch lead to different 
glucose and insulin responses. Carciofi et al. (2008) 
evaluated glucose levels in healthy dogs on six different diets: 
three diets with slowly digestible sources of starch (SDS: 
lentils, peas, and sorghum) and three diets with rapidly 
digestible sources or starch (RDS: maize, cassava, and rice). 
RDS diets resulted in glucose and insulin peaks in a shorter 
timeframe, as well as an average increase in glucose levels 
greater than the one observed in SDS diets. SDS sources 
led to more stable glucose levels for longer periods. These 
findings are in line with a previous study on healthy dogs, 
which also found higher glycemic parameters in rice-
based diets and lower glycemic parameters in sorghum 
and barley-based diets (BOUCHARD; SUNVOLD, 1999). 
A more recent study showed lower peaks and smaller areas 
under the insulin curve with no change in glucose levels, 
indicating higher insulin sensitivity in obese dogs in an 
oral glucose tolerance test performed after 12 weeks of a 
pea-based diet compared to a rice-based diet (ADOLPHE 
et al., 2015). These findings are consistent with those of 
previous studies carried out by the same research group 
showing lower glycemic index of peas when compared to 
rice in healthy dogs (ADOLPHE et al., 2012) and higher 
insulin sensitivity in obese dogs on a low-glycemic index 
diet (MITSUHASHI et al., 2012). The dietary source of 
starch may be related to its digestibility, which in turn 
could have an effect on glucose levels (SILVA JÚNIOR et 
al., 2005; CARCIOFI et al., 2008; BAZOLLI et al., 2015).
Glucose responses vary according to the source of 
starch as well as to the amount ingested (MURRAY et 
al., 1999). Elliott et al. (2012) evaluated three diets with 
different levels of digestible carbohydrate, fiber, and fat, and 
observed that the lowest-carb diet led to lower glucose and 
postprandial triglyceride levels, as well as lower glucose 
peaks when compared to a commercial food for diabetic 
dogs and a commercial food for adult, healthy dogs. The 
authors attributed these effects to the lower starch content, 
and suggested they would be even more significant in dogs 
with DM due to the changes in endocrine control. Monti 
et al. (2016) and Murray et al. (1999) also found decreased 
postprandial glucose levels in healthy dogs, which they 
attributed to the lower starch intake.
Food processing may also result in changes in dogs’ 
postprandial glucose curve. Bazolli et al. (2015) found 
lower starch gelatinization indexes and lower apparent 
digestibility coefficients for some nutrients, including 
starch, according to grain size of rice, sorghum, and corn in 
diets for healthy dogs. Adaptations in processing parameters 
for extruded commercial foods, such as particle size of the 
feedstock and extruder configurations (temperature, shear 
force, retention time, and pressure) could be beneficial, 
preserving part of the naturally-occurring resistant starch, 
which was not affected by grinding or cooking. This finding 
was confirmed by Roberti-Filho (2013), who observed 
significant increase in glucose and insulin parameters of 
healthy dogs receiving extruded foods with more resistant 
starch and lower starch gelatinization due to changes in 
the extruder and increased granulometry of raw materials.
Kimura (2013) applied these same concepts to obese 
dogs. Researchers provided three starch solutions (two 
with resistant starch and one with highly-digestible soluble 
starch) via nasoesophageal tube feeding and also observed 
improved postprandial glucose responses for resistant 
starch.
There is also evidence that resistant starch may promote 
prebiotic effects. In rats, Shen et al. (2011) observed that the 
intake of resistant starch led to increased levels of acetic, 
propionic, and butyric acids, Bacteroides, Bifidobacterium 
spp., Lactobacillus spp., and Clostridium cluster IV in feces, 
also leading to increased levels of serum glucagon-like-
peptide-1 (GLP-1), which would be related to increased 
insulin sensitivity and energy expenditure.
In the first study, in order to consider the effects of starch 
on the glucose levels of diabetic dogs authors provided 
three foods with different starch contents (from 2% to 26% 
of the metabolizable energy [ME]); however, there were 
no glycemic effects. This lack of glucose modulation was 
associated with the fact that diets were not isonutrient, 
with wide variation in fiber levels (3.5 to 5 g / 100 kcal), 
fat (31% to 61% of dry matter [DM])], and protein levels 
(28% to 41% of DM) (FLEEMAN et al., 2009).
In turn, the potential effect of slowly digestible starch 
in diets for diabetic dogs was evaluated by Teshima (2010), 
who analyzed two isonutrient diets with different sources 
of starch: rice versus sorghum and lentil. The sorghum 
and lentil diet resulted in better glycemic control; animals 
showed more stable glucose levels, lower mean and 
minimum glycaemia, and potentially smaller area under 
the glucose curve. Since both diets were isonutrient, these 
effects were attributed to the source of starch.
Teixeira (2016) evaluated the effects of digestible 
carbohydrates in diabetic dogs focused on the source of 
starch and the processing of ingredients. Two isonutrient 
diets were compared, both containing moderate levels of 
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fat and starch and high levels of protein and fiber. Diets 
only differed in their source of starch: peas and barley 
versus corn. The processing of the corn-based diet was 
also controlled, leading to lower starch gelatinization 
index and more resistant starch. After 60 days of treatment 
and the same insulin dose, a 48-hour glucose curve with 
continuous glucose measurement showed lower maximum 
glucose levels, smaller difference between maximum and 
minimum interstitial glucose, longer hypoglycemia, and 
shorter hyperglycemia in the pea and barley group. The 
changes in corn processing were not enough to make it 
equivalent to the slowly digestible starch sources.
Fiber
Blaxter et al. (1990) compared the effects of wheat bran 
and guar gum on the diet of six healthy and four diabetic 
dogs. The inclusion of wheat bran resulted in lower glucose 
variables, which were even lower with guar gum. Results 
were statistically significant for healthy dogs but not for 
DM dogs, perhaps because of the small number of animals 
included in the study. It is worth noting that the nutritional 
profile of the food was not specified, nor was there any 
mention to the amount of fiber added in relation to dry 
matter or energy levels.
Nelson et al. (1991) assessed six dogs with induced 
DM receiving four different diets: high soluble fiber (5 g 
of fiber / 100 kcal, 2.1 g soluble), high insoluble fiber (7 g 
/ 100 kcal, 6 g insoluble), low fiber (2.4 g / 100 kcal, 1.7 g 
insoluble), and control (4.6 g / 100 kcal, 2.3 g insoluble). 
Best glycemic control was achieved with the high-fiber 
diets, mainly the one with highest levels of insoluble 
fiber. However, although the three test diets had similar 
energy levels, the low-fiber and control diets contained 
higher levels of digestible carbohydrates in dry matter. 
The absence of data on nutrient intake, energy content 
of food, and composition of control food hinders data 
interpretation; therefore, the information provided does 
not allow to state that fiber was the sole responsible for 
the change in glucose responses.
Graham et al. (2002) compared the glucose response of 
diabetic dogs on their original diets and on a standardized 
diet with increased fiber content (5.6 g / 100 kcal, 4.6 g of 
insoluble fiber). The standardized diet showed a number 
of benefits: lower 24-hour mean blood glucose levels, 
lower postprandial blood glucose at the second feeding, 
and lower serum concentrations of fructosamine, glycated 
hemoglobin, free glycerol, and cholesterol, as well as 
smaller, more stable glucose curves. However, the original 
diet was not standardized; animals were offered different 
commercial foods and treats; the nutritional profile of 
these diets was not described, and there was no mention to 
starch content. In an apparent preview of this investigation, 
Graham et al. (1994) found better glycemic parameters for 
eight dogs on diets with higher fiber content compared 
to their previous diets (standard commercial dog foods). 
However, the difference was not statistically significant.
Nelson et al. (1998), assessed two diets with similar 
energy distribution for carbohydrate, fat, and protein (6.44 
g fiber / 100 kcal versus 2.7 g / 100 kcal) and observed a 
better glucose control in nine of the 11 DM dogs on the 
higher-fiber diet. These nine dogs showed lower mean 
and fasting blood glucose levels at 24 hours, lower serum 
concentrations of glycated hemoglobin and cholesterol, 
and lower glycosuria; they also required lower doses of 
insulin.
Considering the effects of fiber solubility on the glycemic 
control of DM dogs, Kimmel et al. (2000) compared high 
levels of insoluble fiber (IF; 7.3 g fibers / 100 kcal, less than 
0.01 g soluble), high levels of soluble fiber (SF; 5.6 g / 100 
kcal, 1 g soluble), and low fiber (LF). Although both IF 
and SF contribute to better glycemic control (lower serum 
concentration of fructosamine), their results suggest that 
IF alone may be more beneficial, leading to lower mean 
and maximum glycaemia, lower glycated hemoglobin, and 
smaller area under the glucose curve. Although energy 
distribution between fat, protein, and starch was similar, 
the source of starch was not the same for all diets; that may 
have influenced glucose absorption rates. In addition, the 
IF diet also included higher amounts of total dietary fiber 
when compared to the SF diet. This can also be observed 
by Nelson et al. (1991), where different fiber types did 
not lead to changes in glucose control (except for serum 
glycated hemoglobin, which was lower in the IF diet). 
The higher amount of total dietary fiber in the IF diets 
could explain the better glycemic control, or obfuscate 
the potentially better effects of SF observed by Blaxter and 
Cripps (1990). However, they did not describe the total 
amount of dietary fiber in their diets. Nelson et al. (2000) 
also observed improvements after changing fiber sources 
and increasing levels of SF without increasing total dietary 
fiber.
Fleeman et al. (2009) evaluated three different diets: 
one commercial food with moderate levels of fiber (3.5 g 
/ 100 kcal), low levels of starch (2% ME), and high levels 
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of fat (61% ME); and two diets with high levels of fiber 
(approximately 5 g / 100 kcal), moderate levels of starch 
(26% ME), and varying levels of fat (moderate [31% 
ME] and high [48% ME]). Glucose responses were not 
improved, but the high-fiber diets resulted in better serum 
lipid profiles when compared to the commercial diet, in 
spite of their higher fat content. The conclusion was that 
higher-fiber diets do not lead to better glucose profiles; 
however, different carbohydrate content of commercial 
versus high-fiber diets may have been a confounding factor 
in the interpretation of glucose control: the effects of low 
starch versus the effects of high fiber.
Monti et al. (2016) observed in healthy dogs that diets 
with the same amount of starch did not lead to different 
glucose responses when compared to diets with fiber 
levels ranging from 14% to 24% of the dry matter. Diez 
et al. (1998) reached the same conclusion; no changes in 
glucose levels were observed when they supplemented 
diets with 7% of dry matter as guar gum, inulin, or beet 
fiber. Similarly, Hoenig et al. (2001) did not find changes 
in glucose or lipid profiles in healthy dogs. The variables 
assessed during a glucose tolerance test were fiber amount, 
fermentability, and solubility.
Massimino et al. (1998) assessed the prebiotic and 
fermentative effects of fiber on insulin sensitivity. Healthy 
dogs were fed with high-fermentable fiber or low-
fermentable fiber diets; the first group showed more GLP-1 
and smaller area under the glucose curve. It was found that 
dietary supplementation of prebiotic fructooligosaccharide 
(FOS) to obese dogs led to lower insulin resistance, and this 
finding was attributed to changes in intestinal microbiota 
caused by the prebiotic effects of FOS (RESPONDEK et 
al., 2008).
Many studies have shown the beneficial effects of fibers 
in the glycemic control of dogs with DM. These effects are 
associated with improved insulin sensitivity (MASSIMINO 
et al., 1998; RESPONDEK et al., 2008) as well as delayed 
gastric emptying, starch hydrolysis rate, glucose uptake, and 
prolonged intestinal transit time (MURRAY et al., 1999; 
GRAHAM et al., 2002). However, there is no consensus on 
the recommended type of fiber, and the adverse effects of 
high- fiber diets are as follows: low weight gain; voluminous 
soft stools; flatulence, constipation, and vomiting; decreased 
food palatability, and opaque hair due to the reduced 
availability of other nutrients (NELSON et al., 1991, 1998; 
KIMMEL et al., 2000; HOENIG et al., 2001; GRAHAM et 
al., 2002; FLEEMAN et al., 2009; ZICKER et al., 2010).
Most studies available today focus on fiber type 
and content; further studies on fiber amount and type, 
gastrointestinal effects, and standardized diets are needed 
since added fibers may change/reduce the source of starch, 
which is the key nutrient for the glucose curve. The number 
of potential factors involved in dietary fiber for diabetic 
dogs was discussed by Farcas et al. (2015), which showed 
that levels of total dietary fiber and insoluble fiber in 
commercial foods for diabetic dogs rank among the highest 
in the market.
Fat and energy
Although endocrinopathies alter lipid metabolism 
and lead to hyperlipidemia similar to that caused by the 
lack of insulin in DM dogs (FASCETTI; DELANEY, 2012; 
XENOULIS; STEINER, 2015), data on the influence of 
fat in their diets is still scarce. Controlling lipid levels 
in DM dogs is crucial because increased blood levels of 
cholesterol and triglycerides are related to other conditions 
such as pancreatitis, hepatobiliary diseases, insulin 
resistance, ophthalmopathies, convulsion, lipoma, and 
even atherosclerosis (XENOULIS; STEINER, 2015), which 
has been reported in dogs with DM (SOTTIAUX, 1999).
In this context, Fleeman et al. (2009) observed that 
lower-fat diets, regardless of their fiber content, improved 
lipid profiles in DM dogs; they observed lower plasma 
levels of cholesterol, fatty acids, free glycerol, and also 
potentially reduced triglycerides. Better lipid profiles are 
important for animals with hyperlipidemia or recurrent 
pancreatitis. However, even with adequate amounts of 
food and stable glucose levels, dogs receiving high-fiber, 
low-fat diets showed involuntary weight loss associated 
with increased satiety, lower energy content, and lower 
palatability; owners reported that dogs did not ingest the 
total amount of food prescribed. Thus, a decrease in fat and 
energy contents is not ideal for dogs with adequate body 
condition score (BCS) that are losing weight. However, 
fat can be restricted in DM associated with pancreatitis, 
hyperlipidemia, and obesity; restrictions should be made 
according to these factors and the nutritional assessment 
(NELSON, 1992; ZICKER et al., 2010; FASCETTI; 
DELANEY, 2012).
Teixeira (2016) observed no changes in serum 
triglyceride and cholesterol levels in dogs on low-fat diets 
when compared to higher fat diets that provided better 
glucose control. However, cholesterol and triglyceride 
levels were increased when animals received food with 
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the same amount of fat but a different source of starch, 
leading to poorer glycemic control. In human medicine 
Pelkman (2001) associated lower glycemic index diets with 
better lipid control.
The initial estimate of the maintenance energy 
requirement (MER) should be based on BCS, level of 
physical activity, age, sexual status, and careful nutritional 
assessment. Mathematical equations including body weight 
may be used. For dogs with adequate BCS and low physical 
activity, MER = 95 x BW0.75; for dogs with high physical 
activity, MER = 130 x BW0.75. In weight loss protocols, the 
equation 70 x (0.85 x PC)0.75 is recommended considering 
an initial reduction of 15% in body weight to reach the 
ideal weight (BROOKS et al., 2014). Body condition should 
be assessed through inspection and palpation according 
to the scale validated by Laflamme (1997). The Laflamme 
body condition score states that BCS scores < 4, between 
6-7, and > 8 mean underweight, overweight, and obese, 
respectively.
Obesity
Mattheauws et al. (1984) showed that, in non-diabetic 
and diabetic patients capable of synthetizing and secreting 
insulin, basal concentrations and total secretion of insulin 
increased proportionally to their level of obesity after a 
glucose tolerance test. These findings show that obesity 
may negatively affect glucose tolerance in dogs. Ellmerer 
et al. (2006), German et al. (2009), Brunetto et al. (2011), 
and Ferreira (2016) agree that there is a positive correlation 
between obesity and hyperinsulinemia in dogs. There is 
evidence that hepatic insulin resistance (IR) is responsible 
for higher endogenous glucose production (KIM et al., 
2003), which indicates that obesity plays a key role in the 
response to insulin treatment (NELSON, 1989).
Although DM induced by insulin resistance secondary to 
obesity is less frequent in dogs (FLEEMAN; RAND, 2006), 
weight control and/or reduction is essential. It is known that 
when dogs without DM lose weight they show a decrease 
in hyperinsulinemia, plasma glucose: insulin ratios, and 
IR-related cytokines (GERMAN et al., 2009; BRUNETTO, 
2010; BRUNETTO et al., 2011; VENDRAMINI et al., 2016). 
However, when DM dogs lose weight, their glucose tolerance 
is improved; they become more sensitive to insulin, and 
require lower doses of exogenous insulin. Thus, a weight loss 
protocol should be adopted for overweight dogs as soon as 
the insulin treatment is well established (NELSON, 1988; 
ZICKER et al., 2010; FASCETTI; DELANEY, 2012).
Nutraceutics
Chromium
Although some micronutrients such as zinc, 
manganese, and vitamin A influence glycemic control in 
humans (ZICKER et al., 2010), in dogs only the use of 
chromium was assessed. Chromium is an essential trace 
mineral for dogs. It acts as a cofactor to insulin, influencing 
the cellular uptake of glucose (FASCETTI; DELANEY, 
2012); increased circulating insulin stimulates the entry of 
chromium into insulin-sensitive cells. Chromium binds to 
and activates the oligopeptide chromodulin in the internal 
portion of the insulin receptor that enhances the action 
of this receptor and the glucose metabolism by 18-fold, 
with increased cellular uptake and glucose oxidation 
(PECHOVA; PAVLATA, 2007; MUZÍK et al., 2011).
In humans chromium deficiency may lead to fasting 
hyperglycemia, hyperinsulinemia, glucose intolerance, 
hyperlipidemia, and reductions in active insulin receptors. 
Symptoms are reversed with adequate supplementation; 
however, study findings are inconclusive (PECHOVA; 
PAVLATA, 2007; MUZÍK et al., 2011).
Findings are also controversial in dogs. Spears et 
al. (1998) provided diets with different chromium 
supplementation to healthy dogs and found that animals 
receiving chromium tended to have lower fasting glucose 
levels and higher clearance at glucose tolerance tests 
and insulin challenges, suggesting a beneficial effect of 
chromium on glucose metabolism. Muzík et al. (2011) 
evaluated the response of 17 diabetic dogs receiving 
organic chromium complex supplements and observed 
reduced glucose levels after two weeks of supplementation. 
However, the pre-existing amount of chromium in their diet 
was not mentioned. Schachter et al. (2001) supplemented 
13 diabetic dogs with chromium picolinate and did not find 
improvements in glycemic control in any of the assessed 
variables; this lack of improvement was attributed to the 
amount of chromium in their diet. Finally, Gross et al. 
(2000) showed a potentially deleterious effect of added 
chromium on the glycemic profile of obese dogs. Therefore, 
the evidence of chromium supplementation for glucose 
control in DM dogs is still inconclusive.
Polyunsaturated Fatty Acids Omega-3 series 
(PUFA-3)
Eicosapentaenoic (EPA) and docosahexaenoic 
(DHA) are considered lipid-lowering chemicals. Their 
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mechanisms of action are not fully understood; however, 
potential explanations include regulation of transcription 
factors related to lipogenesis, increased β-oxidation and 
cholesterol secretion via bile, stimulation of lipoprotein 
lipase activity, reduced intestinal absorption of glucose, 
lipids, and cholesterol, and reduction of non-esterified 
fatty acids (SCHENCK, 2005; TOTH et al., 2009; WATTS; 
KARPE, 2011; DENG et al., 2015; XENOULIS; STEINER, 
2015). These effects have been observed in humans, 
laboratory animals, and healthy dogs (FRIEDBERG et al., 
1998; LEBLANC et al., 2005; SCHENCK, 2005), which may 
justify the use of these nutraceuticals in the treatment of 
hyperlipidemic dogs.
Supplementation of PUFA-3 may also be beneficial 
for glycemic control; these benefits have been observed 
in rats and humans (FRIEDBERG et al., 1998; 
OOSTING et al., 2010; ZICKER et al., 2010). Improved 
insulin sensitivity was observed in humans, and was 
associated with the decreased release of non-esterified 
fatty acids from adipocytes and with PUFA-3 agonist 
action on nuclear transcription factors such as PPAR-α, 
PPAR-γ, and GPR-120 receptors, which are related to 
insulin resistance (ALBERT et al., 2014). However, this 
finding was only assessed in healthy animals, where 
supplementation promoted changes in the lipid profiles 
of erythrocyte cell membranes; no changes in glucose 
and insulin variables were observed in the oral glucose 
tolerance test (IRVINE et al., 2002).
β-glucans
β-glucans are soluble fibers found in yeast cell walls 
and cereal endosperm (CLOETENS et al., 2012). They are 
considered nutraceuticals due to their beneficial effects 
for different species, including dogs. In humans and in 
rats dietary supplements of Β-glucans have been shown 
to reduce glucose and lipid levels (DROZDOWSKI et 
al., 2010; CLOETENS et al., 2012; BROCKMAN et 
al., 2013). In addition to their intrinsic characteristics 
(modulation of viscosity, speed, and enzyme access 
to the gut), the benefits of β-glucans may be due to 
their influence in the expression of genes related to the 
synthesis of fatty acids and cholesterol (DROZDOWSKI 
et al., 2010; CLOETENS et al., 2012).
Ferreira (2016) found positive effects of a diet 
supplemented with 0.1% of β-glucan, leading to 
reductions in serum glucose, insulin, cholesterol, and 
triglycerides in insulin-resistant obese dogs. The same 
hypoglycemic effect was observed with the inclusion of 
15 and 25 mg of β-glucan / kg of diet/day in dogs with 
streptozotocin-induced hyperglycemia (VETVICKA; 
OLIVEIRA, 2014).
Food management
The feeding schedule of dogs with DM should 
be planned to minimize postprandial blood glucose 
fluctuations, such as setting meal times according to 
insulin applications (NELSON; LEWIS, 1990). Although 
several possible feeding schedules have been described 
(NELSON, 1988, 1992; BARTGES, 2005; FLEEMAN; 
RAND, 2006; ZICKER et al., 2010), there are only two 
results available in this context. Nelson (1989) observed 
that diabetic dogs receiving one insulin application and 
two meals a day (2/3 of the MER at application and 
1/3 after 10 hours) obtained better glycemic control 
than dogs fed one single daily meal simultaneous to 
the insulin application, or one single daily meal 10 
hours after application. TESHIMA (2010) compared 
the use of the same food under two dietary management 
schedules: one meal every 12 hours with subsequent 
insulin applications versus one third meal between the 
two insulin applications. In the first schedule, animals 
showed lower glycemic fluctuations in the postprandial 
curve; in the second management schedule, half of them 
presented hypoglycemic episodes at least one point of 
the curve. Thus, with one or two insulin applications, 
glycemic control is best achieved with two meals a day 
(FLEEMAN; RAND, 2006).
Types of diet
In order to achieve adequate glycemic control without 
fluctuating glucose levels it is essential that the diet be 
consistent in terms of ingredients, as well as quantity, 
quality, and type of processing. This is an advantage 
of high-quality, industrialized foods; they offer fixed 
formulations and standardized ingredients (NELSON; 
LEWIS, 1990; ROBERTI-FILHO, 2013). Commercial 
foods are divided into three main categories: dry, semi-
moist, and moist. All three options were offered to 
healthy dogs, and glycemic and insulin responses were 
increased in the semi-moist group. These effects were 
attributed to the presence of corn syrup (HOLSTE et 
al., 1989); some mono- and disaccharides are used as 
humectants in order to reduce water activity and prevent 
growth of contaminating organisms in semi-moist foods 
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(CASE et al., 2011), which makes them contraindicated 
for DM dogs (NELSON, 1989; FASCETTI; DELANEY, 
2012).
Also, care should be exercised when deciding on 
food variation or ingredient substitution according to 
availability and cost (NELSON; LEWIS, 1990), which 
can also occur in homemade foods. Homemade diets 
are optimal in terms of palatability, which is key for the 
consumption of adequate amounts of food. However, 
owners may not comply with prescriptions (OLIVEIRA 
et al., 2014; JOHNSON et al., 2016; HALFEN et al., 
2017); homemade diets are also questionable in terms of 
consistency, balance, and food safety (MICHEL, 2006).
Conclusion
The current guidelines for the management of dogs with 
DM is the maintenance of constant energy content, meal 
times, and nutritional profile through foods that minimize 
postprandial blood glucose fluctuations. Dietary fiber 
enhancement may be useful; however, the source of starch 
included in the diabetic dog’s diet must be chosen carefully.
The evidence currently available is scarce. Further 
research should focus on postprandial effects of starch 
and fiber, effects of incretin and microbiota, types of foods 
and feeding schedules, and use of nutraceuticals such as 
chromium, PUFA-3s, and β-glucans to better control 
glucose and lipid levels.
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